HUTCHMED (China) Limited (HCM) Earnings History
Profitable21 years of earnings data (2005–2025) · Positive TTM net income
Loading earnings history...
HUTCHMED (China) Limited (HCM) Earnings Overview
As of July 7, 2026, HUTCHMED (China) Limited (HCM) reported trailing twelve-month net income of $467M, reflecting +1081.8% year-over-year growth. The company earned $2.68 per diluted share over the past four quarters, with a net profit margin of 83.3%.
Looking at the long-term picture, HCM's historical earnings data spans multiple years. The company achieved its highest annual net income of $458M in fiscal 2025, representing a new all-time high.
HUTCHMED (China) Limited maintains industry-leading profitability with a gross margin of 38.7%, operating margin of -10.0%, and net margin of 83.3%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including ZLAB (-$178M net income, -38.1% margin), LEGN (-$250M net income, -28.8% margin), CAN (-$210M net income, -39.7% margin), HCM has outperformed on profitability metrics. Compare HCM vs ZLAB →
HCM Earnings vs Peers
Earnings metrics vs comparable public companies
HCM Historical Earnings Data (2005–2025)
21 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $458M | +1114.2% | -$55M | $2.60 | 83.3% | -10.0% |
| 2024 | $38M | -62.6% | -$44M | $0.22 | 6.0% | -6.9% |
| 2023 | $101M | +127.9% | $18M | $0.60 | 12.0% | 2.2% |
| 2022 | -$361M | -85.4% | -$410M | $-2.15 | -84.6% | -96.1% |
| 2021 | -$195M | -54.8% | -$328M | $-1.25 | -54.7% | -92.2% |
| 2020 | -$126M | -18.6% | -$199M | $-0.90 | -55.2% | -87.1% |
| 2019 | -$106M | -41.7% | -$153M | $-0.80 | -51.7% | -74.6% |
| 2018 | -$75M | -179.8% | -$93M | $-0.55 | -34.9% | -43.3% |
| 2017 | -$27M | -328.6% | -$53M | $-0.22 | -11.1% | -22.1% |
| 2016 | $12M | +46.4% | -$47M | $0.10 | 5.4% | -21.6% |
| 2015 | $8M | +124.4% | -$10M | $-0.32 | 4.5% | -5.5% |
| 2014 | -$33M | -654.8% | -$18M | $-0.33 | -37.6% | -20.9% |
| 2013 | $6M | +62.6% | -$1M | $0.06 | 12.9% | -2.3% |
| 2012 | $4M | +412.2% | -$17M | $0.03 | 16.3% | -77.9% |
| 2011 | $710,223 | +110.3% | $4M | $0.01 | 0.4% | 2.5% |
| 2010 | -$7M | +21.5% | -$2M | $-0.07 | -5.1% | -1.6% |
| 2009 | -$9M | +50.7% | -$5M | $-0.09 | -7.9% | -4.2% |
| 2008 | -$18M | -3.3% | -$14M | $-0.17 | -20.4% | -16.4% |
| 2007 | -$17M | -78.9% | -$10M | $-0.17 | -26.4% | -14.9% |
| 2006 | -$10M | -41.8% | -$5M | $-0.10 | -19.0% | -10.7% |
| 2005 | -$7M | - | -$6M | $-0.09 | -17.9% | -15.1% |
Download Data
Export HCM earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
21+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
HCM — Frequently Asked Questions
Quick answers to the most common questions about buying HCM stock.
What is HCM earnings per share (EPS)?
HCM trailing twelve-month (TTM) diluted EPS is $2.68, reflecting +1081.8% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2005 to 2025 is available in the table on this page.
What is HUTCHMED (China) Limited's net income?
HUTCHMED (China) Limited (HCM) trailing twelve-month net income is $467M as of 2025. Earnings grew +1081.8% year-over-year. HUTCHMED (China) Limited has been profitable for 3 consecutive years.
Is HCM profitable?
Yes, HCM is profitable with a TTM net income of $467M and a net profit margin of +83.3%. HUTCHMED (China) Limited has generated profits for 3 consecutive years.
What is HCM's earnings growth rate?
HCM compound annual EPS growth rates (CAGR): 1-Year: +1081.8%, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2005 to 2025.
What are HCM's profit margins?
HUTCHMED (China) Limited net profit margin is +83.3%, operating margin is -10.0%, and gross margin is +38.7%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is +45.3%.
Is HCM growing earnings?
Yes, HCM earnings are accelerating — EPS growth of +1081.8% exceeds the 5-year CAGR of N/A. TTM net income reached $467M. Earnings momentum is strengthening.
What was HCM's best earnings year?
HUTCHMED (China) Limited's highest annual net income on record is $458M, achieved in fiscal year 2025. Earnings history on this page spans 2005 to 2025 and includes all annual and quarterly figures.
What were HCM's earnings last quarter?
HCM's most recent reported quarter was Q2 2025. Net income was $227M with diluted EPS of $1.30. For a full breakdown of all quarters, see the quarterly earnings table on this page.